Atlas Trials

Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer

Clinical trial NCT05071053 · TERMINATED

Trial details

NCT number
NCT05071053
Sponsor
Sanofi
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Adenocarcinoma GastricGastrooesophageal Cancer
Start date
2021-11-16
Primary completion
2023-06-23
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.